Cardio-vascular Energy Transfer and Ventriculo-arterial Coupling in Heart Failure

Heart Failure, Left-sided Clinical Trial

Official title:

Cardio-vascular Energy Transfer and Ventriculo-arterial Coupling in Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06200246
• Other study ID #: 480738
• Status: Completed
• Start date: October 1, 2022
• Est. completion date: July 1, 2023

Study information

• Verified date: December 2023
• Source: St. Olavs Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this pilot study is to investigate energy transfer fram the ventricle to the arteries in patients with heart failure, primary by investigating the total power.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: July 1, 2023
• Est. primary completion date: July 1, 2023
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Acute left ventricular failure due to:

• Myocardial ischemia
• Cardiomyopathy
• Myocarditis Sinus rhythm Age >18 years Exclusion Criteria: Cardiogenic shock Mechanical circulatory support Respiratory treatment Inotropic infusions Tachyarrhythmias Lack of capacity to consent

Related Conditions & MeSH terms

• Heart Failure
• Heart Failure, Left-sided

Locations

Country	Name	City	State
Norway	St Olav hospital	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
St. Olavs Hospital	National Taiwan Normal University

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardio vascular energy transfer in heart failure patients.	We are investigating cardio vascular energy transfer in heart failure patients by calculating total power.	During first 1-3 days after admission to hospital because of decompensated heart failure.